- Home
- KSS vs PRCT Comparison
KSS vs PRCT Comparison
Compare KSS & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSS
- PRCT
- Stock Information
- Founded
- KSS 1962
- PRCT 2009
- Country
- KSS United States
- PRCT United States
- Employees
- KSS N/A
- PRCT N/A
- Industry
- KSS Department/Specialty Retail Stores
- PRCT Medical Specialities
- Sector
- KSS Consumer Discretionary
- PRCT Health Care
- Exchange
- KSS Nasdaq
- PRCT Nasdaq
- Market Cap
- KSS 2.0B
- PRCT 2.0B
- IPO Year
- KSS 1992
- PRCT 2021
- Fundamental
- Price
- KSS $15.42
- PRCT $28.01
- Analyst Decision
- KSS Sell
- PRCT Buy
- Analyst Count
- KSS 14
- PRCT 9
- Target Price
- KSS $11.88
- PRCT $63.50
- AVG Volume (30 Days)
- KSS 3.8M
- PRCT 1.6M
- Earning Date
- KSS 11-26-2025
- PRCT 11-04-2025
- Dividend Yield
- KSS 3.24%
- PRCT N/A
- EPS Growth
- KSS N/A
- PRCT N/A
- EPS
- KSS 1.86
- PRCT N/A
- Revenue
- KSS $15,886,000,000.00
- PRCT $299,907,000.00
- Revenue This Year
- KSS N/A
- PRCT $48.38
- Revenue Next Year
- KSS N/A
- PRCT $30.87
- P/E Ratio
- KSS $8.29
- PRCT N/A
- Revenue Growth
- KSS N/A
- PRCT 50.07
- 52 Week Low
- KSS $6.04
- PRCT $27.87
- 52 Week High
- KSS $21.39
- PRCT $100.89
- Technical
- Relative Strength Index (RSI)
- KSS 41.35
- PRCT 26.87
- Support Level
- KSS $16.27
- PRCT $29.78
- Resistance Level
- KSS $18.75
- PRCT $32.52
- Average True Range (ATR)
- KSS 0.94
- PRCT 1.43
- MACD
- KSS -0.20
- PRCT -0.40
- Stochastic Oscillator
- KSS 16.28
- PRCT 1.53
About KSS Kohl's Corporation
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.